Skip to main content

Gastrointestinal Disease Tied to High Physical, Financial Burden

Medically reviewed by Carmen Pope, BPharm. Last updated on April 18, 2025.

By Lori Solomon HealthDay Reporter

FRIDAY, April 18, 2025 -- Gastrointestinal (GI) diseases are responsible for a considerable and growing burden of health care use and costs within the United States, according to a study recently published online in Gastroenterology.

Anne F. Peery, M.D., from the University of North Carolina at Chapel Hill, and colleagues estimated the burden and costs associated with GI diseases in the United States.

The researchers found that in 2021, GI health care expenditures totaled $111.8 billion. An estimated 14.5 million emergency department visits and 2.9 million hospital admissions resulted from a GI diagnosis or symptom. One in six U.S. adults reported having one or more frequent GI symptoms in the past three months. Diagnoses of 315,065 new GI cancers were made, and GI diseases caused 281,413 deaths. An estimated 23.5 million GI endoscopies were performed in 2022. The National Institutes of Health supported $3.6 billion for GI research in 2023, representing 7.4 percent of its budget.

"Our report captures the remarkable and changing burden of GI diseases in the United States," the authors write. "There is an ongoing need to support GI sciences, which offers the promise of preventing or treating these highly prevalent and morbid conditions. There is also clearly an extraordinary demand for specialized teams that practice GI medicine and provide the daily support and care for patients with GI diseases."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted April 2025

Read this next

Digestive Disease Week, May 3-6

Digestive Disease Week, the annual meeting sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association, American Society for...

Spatiotemporal Mapping IDs Four Stages of Inflammatory Bowel Disease Evolution

TUESDAY, May 6, 2025 -- Machine learning has enabled spatiotemporal mapping of the four stages of the evolution of inflammatory bowel disease (IBD), according to a study published...

Guidelines Developed for Management of Gastric Premalignant Conditions

TUESDAY, March 25, 2025 -- In a clinical guideline issued by the American College of Gastroenterology and published online March 12 in the American Journal of...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.